182 related articles for article (PubMed ID: 8375854)
1. Expression of interleukin-6 in Castleman's disease.
Hsu SM; Waldron JA; Xie SS; Barlogie B
Hum Pathol; 1993 Aug; 24(8):833-9. PubMed ID: 8375854
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies.
Menke DM; Tiemann M; Camoriano JK; Chang SF; Madan A; Chow M; Habermann TM; Parwaresch R
Am J Clin Pathol; 1996 Mar; 105(3):268-76. PubMed ID: 8602606
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 gene expression in Castleman's disease.
Leger-Ravet MB; Peuchmaur M; Devergne O; Audouin J; Raphael M; Van Damme J; Galanaud P; Diebold J; Emilie D
Blood; 1991 Dec; 78(11):2923-30. PubMed ID: 1954381
[TBL] [Abstract][Full Text] [Related]
4. Castleman's disease.
Palestro G; Turrini F; Pagano M; Chiusa L
Adv Clin Path; 1999; 3(1-2):11-22. PubMed ID: 10655569
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
Nishi J; Maruyama I
Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.
Hsu SM; Xie SS; Hsu PL; Waldron JA
Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458
[TBL] [Abstract][Full Text] [Related]
7. Expression of ICAM-1, VCAM-1 and ELAM-1 in angiofollicular lymph node hyperplasia (Castleman's disease): evidence for dysplasia of follicular dendritic reticulum cells.
Ruco LP; Gearing AJ; Pigott R; Pomponi D; Burgio VL; Cafolla A; Baiocchini A; Baroni CD
Histopathology; 1991 Dec; 19(6):523-8. PubMed ID: 1723957
[TBL] [Abstract][Full Text] [Related]
8. IL-6-positive classical Hodgkin's lymphoma co-occurring with plasma cell type of Castleman's disease: report of a case.
Momoi A; Kojima M; Sakai T; Ajiro J; Isahai N; Nagai K; Aoki S
Int J Hematol; 2013 Feb; 97(2):275-9. PubMed ID: 23359301
[TBL] [Abstract][Full Text] [Related]
9. Primary marginal zone B-cell lymphoma of the lymph node resembling plasmacytoma arising from a plasma cell variant of Castleman's disease. A clinicopathological and immunohistochemical study of seven patients.
Kojima M; Nakamura S; Motoori T; Shimano S; Murayama K; Tamaki Y; Shimizu K; Oyama T; Sugihara S; Sakata N; Masawa N
APMIS; 2002 Dec; 110(12):875-80. PubMed ID: 12645666
[TBL] [Abstract][Full Text] [Related]
10. A case of multicentric Castleman's disease demonstrating severe eosinophilia and enhanced production of interleukin-5.
Ishii T; Tatekawa T; Koseto M; Ishii M; Kobayashi H; Koike M; Fujii T; Saeki Y
Eur J Haematol; 2003 Feb; 70(2):115-8. PubMed ID: 12581193
[TBL] [Abstract][Full Text] [Related]
11. Increased interleukin-6 (IL-6) production in a young child with clinical and pathologic features of multicentric Castleman's disease.
Kinney MC; Hummell DS; Villiger PM; Hourigan A; Rollins-Smith L; Glick AD; Lawton AR
J Clin Immunol; 1994 Nov; 14(6):382-90. PubMed ID: 7883866
[TBL] [Abstract][Full Text] [Related]
12. Dissolution of the lymphoid follicle is a feature of the HHV8+ variant of plasma cell Castleman's disease.
Amin HM; Medeiros LJ; Manning JT; Jones D
Am J Surg Pathol; 2003 Jan; 27(1):91-100. PubMed ID: 12502931
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor expression in follicular dendritic cells: a shared feature of follicular dendritic cell sarcoma and Castleman's disease.
Sun X; Chang KC; Abruzzo LV; Lai R; Younes A; Jones D
Hum Pathol; 2003 Sep; 34(9):835-40. PubMed ID: 14562277
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease.
Yoshizaki K; Matsuda T; Nishimoto N; Kuritani T; Taeho L; Aozasa K; Nakahata T; Kawai H; Tagoh H; Komori T
Blood; 1989 Sep; 74(4):1360-7. PubMed ID: 2788466
[TBL] [Abstract][Full Text] [Related]
15. Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease.
Nishi J; Arimura K; Utsunomiya A; Yonezawa S; Kawakami K; Maeno N; Ijichi O; Ikarimoto N; Nakata M; Kitajima I; Fukushige T; Takamatsu H; Miyata K; Maruyama I
Br J Haematol; 1999 Mar; 104(3):482-5. PubMed ID: 10086783
[TBL] [Abstract][Full Text] [Related]
16. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease.
Sato Y; Kojima M; Takata K; Morito T; Asaoku H; Takeuchi T; Mizobuchi K; Fujihara M; Kuraoka K; Nakai T; Ichimura K; Tanaka T; Tamura M; Nishikawa Y; Yoshino T
Mod Pathol; 2009 Apr; 22(4):589-99. PubMed ID: 19270642
[TBL] [Abstract][Full Text] [Related]
17. [Castleman disease. Histopathological and immunohistochemical analysis of 39 cases].
Sevilla-Lizcano DB; Frias-Soria CL; Ortiz-Hidalgo C
Gac Med Mex; 2017; 153(5):550-558. PubMed ID: 29099112
[TBL] [Abstract][Full Text] [Related]
18. Follicular lymphoma with hyaline-vascular Castleman-like features: analysis of 6 cases and review of the literature.
Pina-Oviedo S; Miranda RN; Lin P; Manning JT; Medeiros LJ
Hum Pathol; 2017 Oct; 68():136-146. PubMed ID: 28873356
[TBL] [Abstract][Full Text] [Related]
19. "Follicular variant" of hyaline-vascular type of Castleman's disease: histopathological and immunohistochemical study of 11 cases.
Kojima M; Shimizu K; Ikota H; Ohno Y; Motoori T; Itoh H; Masawa N; Nakamura S
J Clin Exp Hematop; 2008 Nov; 48(2):39-45. PubMed ID: 19039195
[TBL] [Abstract][Full Text] [Related]
20. Progressive transformation of germinal center presenting with histological features of hyaline-vascular type of Castleman's disease.
Kojima M; Nakamura S; Miyawaki S; Ohno Y; Sakata N; Masawa N
APMIS; 2005 Apr; 113(4):288-95. PubMed ID: 15865611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
